Cargando…
Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors
The paper provides the issues regarding the body composition change by sodium–glucose cotransporter 2 inhibitors.[Image: see text]
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400153/ https://www.ncbi.nlm.nih.gov/pubmed/30369086 http://dx.doi.org/10.1111/jdi.12966 |
_version_ | 1783399901865967616 |
---|---|
author | Sasaki, Takashi |
author_facet | Sasaki, Takashi |
author_sort | Sasaki, Takashi |
collection | PubMed |
description | The paper provides the issues regarding the body composition change by sodium–glucose cotransporter 2 inhibitors.[Image: see text] |
format | Online Article Text |
id | pubmed-6400153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64001532019-03-14 Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors Sasaki, Takashi J Diabetes Investig Editorial The paper provides the issues regarding the body composition change by sodium–glucose cotransporter 2 inhibitors.[Image: see text] John Wiley and Sons Inc. 2018-11-30 2019-03 /pmc/articles/PMC6400153/ /pubmed/30369086 http://dx.doi.org/10.1111/jdi.12966 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Editorial Sasaki, Takashi Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
title | Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
title_full | Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
title_fullStr | Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
title_full_unstemmed | Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
title_short | Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
title_sort | sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400153/ https://www.ncbi.nlm.nih.gov/pubmed/30369086 http://dx.doi.org/10.1111/jdi.12966 |
work_keys_str_mv | AT sasakitakashi sarcopeniafrailtycircleandtreatmentwithsodiumglucosecotransporter2inhibitors |